The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Adaptive Radiotherapy Software Market Over The Period 2026–2030?
The adaptive radiotherapy software market has experienced substantial growth in recent times. This market is projected to expand from $0.7 billion in 2025 to $0.81 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.3%. Historically, this expansion has been driven by factors such as the increasing adoption of image-guided radiotherapy, a global rise in cancer incidence, continuous advancements in radiation oncology software, the growing demand for improved treatment accuracy, and the proliferation of radiotherapy centers.
The adaptive radiotherapy software market is projected to experience swift expansion in the coming years. This market is anticipated to reach a valuation of $1.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.0%. Several factors are contributing to this growth during the forecast period, including an escalating need for individualized cancer therapies, the incorporation of AI-powered treatment customization, increased uptake of cloud-based oncology solutions, a heightened emphasis on minimizing radiation side effects, and significant investments in sophisticated oncology infrastructure. Key trends anticipated during this period encompass dynamic treatment planning, dose optimization guided by imaging, bespoke radiation therapy protocols, automation of workflows in radiation oncology, and the integration of multiple imaging modalities.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28114&type=smp
Which Economic Or Industry Drivers Are Impacting The Adaptive Radiotherapy Software Market?
An increasing incidence of cancer is projected to fuel the expansion of the adaptive radiotherapy software market in the future. Cancer cases denote the count of people diagnosed with the disease within a particular demographic during a set timeframe. The prevalence of cancer is escalating among older demographics because extended life expectancies result in more genetic mutations accumulating, thereby heightening the likelihood of developing the illness. Adaptive radiotherapy software aids in cancer therapy by dynamically modifying radiation doses according to alterations in tumor dimensions, form, and the patient’s anatomical structure, thereby enhancing accuracy, optimizing tumor localization, and reducing harm to healthy cells. For example, as reported by Cancer Australia, an Australian government body, in February 2025, a total of 4,641 new pancreatic cancer diagnoses occurred in 2024, comprising 2,414 in men and 2,227 in women. Consequently, the growing occurrence of cancer cases is a significant impetus behind the expansion of the adaptive radiotherapy software market.
How Is The Adaptive Radiotherapy Software Market Divided Into Its Major Segments?
The adaptive radiotherapy software market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Prostate Cancer, Head And Neck Cancer, Breast Cancer, Lung Cancer, Other Applications
4) By End User: Hospitals, Cancer Treatment Centers, Research Institutes, Other End-Users
Subsegments:
1) By Software: Treatment Planning Software, Workflow Management Software, Imaging And Visualization Software
2) By Services: Implementation And Integration Services, Maintenance And Consulting Services, Training And Support Services
How Are Trends Transforming The Adaptive Radiotherapy Software Market Landscape?
Companies operating primarily within the adaptive radiotherapy software market are concentrating on advancing technological innovations, specifically the AI-powered, adaptive CT-Linac, with the goal of improving real-time tumor targeting, enhancing treatment accuracy, and optimizing patient outcomes. This AI-powered, adaptive CT-Linac system constitutes a radiation therapy approach that integrates computed tomography (CT) imaging with a linear accelerator (Linac), utilizing artificial intelligence (AI) to dynamically adjust and refine radiation delivery in real time, responding to variations in tumor dimensions, configuration, and placement throughout the treatment process. An illustrative example occurred in May 2024, when Elekta AB, a medication company based in Sweden, unveiled Evo, which is engineered for accurate and effective radiotherapy procedures. Evo is specifically crafted to provide exceptionally personalized and precise cancer radiation therapy. It incorporates sophisticated AI-augmented imaging capabilities, empowering medical professionals to visualize tumors with remarkable detail and modify treatments either instantaneously or between sessions. The objectives of Evo are to elevate treatment exactness, minimize adverse effects, and improve patients’ overall quality of life, simultaneously providing clinics with the flexibility to integrate cutting-edge technology at a comfortable rate.
Who Are The Prominent Organizations Shaping The Adaptive Radiotherapy Software Market?
Major companies operating in the adaptive radiotherapy software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., United Imaging Healthcare Co. Ltd., Brainlab AG, Accuray Incorporated, RaySearch Laboratories AB, ViewRay Inc., C-RAD AB, Standard Imaging Inc., LAP GmbH Laser Applikationen, Oncology Systems Limited, DOSIsoft SA, Mirada Medical Ltd., Limbus AI, MagnetTx Oncology Solutions Ltd., Spectronic Medical AB, Akesis Inc.
Read the full adaptive radiotherapy software market report here:
What Are The Top-Performing Regions Within The Adaptive Radiotherapy Software Market?
North America was the largest region in the adaptive radiotherapy software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adaptive radiotherapy software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Adaptive Radiotherapy Software Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=28114&type=smp
Browse Through More Reports Similar to the Global Adaptive Radiotherapy Software Market 2026, By The Business Research Company
Single Dose Radiotherapy Services Market Report 2026
Image Guided Radiation Therapy Market Report 2026
Radiation Dose Management Market Report 2026
https://www.thebusinessresearchcompany.com/report/radiation-dose-management-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model